Skip to main content

Table 1 Demographic and clinical characteristics of study groups defined by BMI

From: Normal weight diabetic patients versus obese diabetics: relation of overall and abdominal adiposity to vascular health

Variables Group 1 Group 2 Group 3
DM-Ob- DM + Ob- DM + Ob+
Age (years) 56.2 ± 12.2 66.7 ± 8.4* 61.4 ± 8.7
BMI (kg/m2) 24.8 ± 2.3 25.5 ± 2.4 34.2 ± 3.7*
Hypertension 10% 64.5%* 63.3%*
Smoker 8.3% 22.6%* 15.2%
Aspirin use 5.6% 53%* 39%*
Insulin use 0.0% 29%* 36.7%*
Metformin use 0.0% 80.6%* 69.6%*
ACEI/ARB use 16.0% 64.5%* 63.3%*
CC Blocker use 14.6% 38.7%* 32.9%
Beta blocker use 16.76% 48.4%* 46.8%*
Statin use 13.2% 69.4%* 58.2%*
Fasting plasma glucose(mg/dl) 93.4 ± 9.8 147.9 ± 43.9* 164.4 ± 58.4*
HbA1C (%) 5.9 ± 0.4 7.4 ± 1.4* 8.1 ± 1.7*
Low density lipoprotein cholesterol (mg/dl) 119.0 ± 31.6 99.0 ± 30.3 93.8 ± 29.3*
High density lipoprotein cholesterol (mg/dl) 53.7 ± 12.0 46.3 ± 10.4* 45.1 ± 13.1*
Triglycerides (mg/dl) 119.0 ± 59.1 144.3 ± 104.8 166.0 ± 109.3*
C-reactive protein (mg/dl) 0.3 ± 0.3 0.5 ± 0.8* 0.9 ± 1.3*
HOMA IR 1.9 ± 1.2 6.0 ± 13.0 10.9 ± 17.7*
Creatinine (mg/dl) 0.9 ± 1.2 1.1 ± 0.9* 1.0 ± 0.5*
Systolic blood pressure (mmHg) 124.7 ± 15.6 141.4 ± 19.9* 154.1 ± 20.1*
Diastolic blood pressure (mmHg) 69.3 ± 9.0 74.1 ± 9.6* 78.7 ± 9.9*
AI(%) 29.6 ± 9.6 36.8 ± 8.8* 35.6 ± 11.3*
PWV (m/sec) 6.1 ± 1.0 7.5 ± 2.7* 7.5 ± 3.2*
  1. By-group comparisons made using one way analysis of variance (ANOVA) simultaneously comparing all three groups.
  2. *p-value vs. group 1 (significant at the 0.05 level).